Paroxetine Mesylate Patent Expiration
Paroxetine Mesylate is Used for managing moderate to severe vasomotor symptoms associated with menopause. It was first introduced by Sebela Ireland Ltd
Paroxetine Mesylate Patents
Given below is the list of patents protecting Paroxetine Mesylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Brisdelle | US8658663 | Method of treating thermoregulatory disfunction with paroxetine | Apr 06, 2029 | Legacy Pharma |
| Brisdelle | US8946251 | Method of treating thermoregulatory dysfunction with paroxetine | Aug 04, 2026 | Legacy Pharma |
| Brisdelle | US9393237 | Method of treating thermoregulatory dysfunction with paroxetine | Aug 04, 2026 | Legacy Pharma |
| Brisdelle | US7598271 | Crystalline paroxetine methane sulfonate |
May 04, 2025
(Expired) | Legacy Pharma |
| Pexeva | US7598271 | Crystalline paroxetine methane sulfonate |
May 04, 2025
(Expired) | Sebela Ireland Ltd |
| Brisdelle | US5874447 | 4-Phenylpiperidine compounds for treating depression |
Jun 10, 2017
(Expired) | Legacy Pharma |
| Pexeva | US5874447 | 4-Phenylpiperidine compounds for treating depression |
Jun 10, 2017
(Expired) | Sebela Ireland Ltd |
Paroxetine Mesylate's Family Patents
Explore Our Curated Drug Screens
Paroxetine Mesylate Generic API Manufacturers
Several generic applications have been filed for Paroxetine Mesylate. The first generic version for Paroxetine Mesylate was by Actavis Laboratories Fl Inc and was approved on Jun 20, 2017. And the latest generic version is by Prinston Pharmaceutical Inc and was approved on Aug 18, 2017.
Given below is the list of companies who have filed for Paroxetine Mesylate generic, along with the locations of their manufacturing plants worldwide.
1. ACTAVIS LABS FL INC
Actavis Laboratories Fl Inc has filed for 1 generic for Paroxetine Mesylate. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 7.5MG BASE | capsule | Prescription | ORAL | AB | Jun 20, 2017 |
2. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 1 generic for Paroxetine Mesylate. Given below are the details of the strengths of this generic introduced by Prinston Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 7.5MG BASE | capsule | Prescription | ORAL | AB | Aug 18, 2017 |